Blood miRNAs as Potential Diagnostic Biomarkers for Chronic Obstructive Pulmonary Disease: A Meta-Analysis

References

• Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD Executive Summary. Am J Respir Crit Care Med. 2023;207(7):819–837. doi:10.1164/rccm.202301-0106PP
   PubMed Web of Science ®Google Scholar
• Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/S0140-6736(20)30925-9
   PubMed Web of Science ®Google Scholar
• Li HY, Gao TY, Fang W, et al. Global, regional and national burden of chronic obstructive pulmonary disease over a 30-year period: estimates from the 1990 to 2019 Global Burden of Disease Study. Respirology. 2023;28(1):29–36. doi:10.1111/resp.14349
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health CPH study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Yu S, Zhang J, Fang Q, et al. Blood eosinophil levels and prognosis of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. Am J Med Sci. 2021;362(1):56–62. doi:10.1016/j.amjms.2021.02.013
   PubMed Web of Science ®Google Scholar
• Qian Y, Cai C, Sun M, et al. Analyses of factors associated with acute exacerbations of chronic obstructive pulmonary disease: a review. Int J Chron Obstruct Pulmon Dis. 2023;18:2707–2723. doi:10.2147/COPD.S433183
   PubMed Web of Science ®Google Scholar
• Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1065–1072. doi:10.1164/rccm.201110-1792OC
   PubMed Web of Science ®Google Scholar
• Liao Y, Wang R, Wen F. Diagnostic and prognostic value of long noncoding RNAs in sepsis: a systematic review and meta-analysis. Expert Rev Mol Diagn. 2022;22(8):821–831. doi:10.1080/14737159.2022.2125801
   PubMed Web of Science ®Google Scholar
• Zhong S, Chen C, Yang L, et al. Identification of circRNA-associated ceRNA networks in peripheral blood mononuclear cells as potential biomarkers for chronic obstructive pulmonary disease. Biosci Rep. 2023;43(10):BSR20230005. doi:10.1042/BSR20230005
   PubMed Web of Science ®Google Scholar
• Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509–524. doi:10.1038/nrm3838
   PubMed Web of Science ®Google Scholar
• Zhu M, Ye M, Wang J, et al. Construction of potential miRNA-mRNA regulatory network in COPD plasma by bioinformatics analysis. Int J Chron Obstruct Pulmon Dis. 2020;15:2135–2145. doi:10.2147/COPD.S255262
   PubMed Web of Science ®Google Scholar
• Wang C, Feng D, Dong S, et al. Dysregulated circulating microRNA-126 in chronic obstructive pulmonary disease: linkage with acute exacerbation risk, severity degree, and inflammatory cytokines. J Clin Lab Anal. 2022;36(3):e24204. doi:10.1002/jcla.24204
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. doi:10.7326/0003-4819-155-8-201110180-00009
   PubMed Web of Science ®Google Scholar
• Devillé WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2002;2(1):9. doi:10.1186/1471-2288-2-9
   PubMedGoogle Scholar
• Chu H, Cole SR. Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol. 2006;59(12):1331–1332; author reply 1332–1333. doi:10.1016/j.jclinepi.2006.06.011
   Web of Science ®Google Scholar
• Reitsma JB, Glas AS, Rutjes AW, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982–990. doi:10.1016/j.jclinepi.2005.02.022
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang Z, Chen L, et al. miRNA‑101‑3p.1 as an independent diagnostic biomarker aggravates chronic obstructive pulmonary disease via activation of the EGFR/PI3K/AKT signaling pathway. Mol Med Rep. 2019;20(5):4293–4302. doi:10.3892/mmr.2019.10657
   PubMed Web of Science ®Google Scholar
• Ding Y, Tang S, Zhou Z, et al. Plasma miR-150-5p as a Biomarker for Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2023;18:399–406. doi:10.2147/COPD.S400985
   PubMedGoogle Scholar
• Gao J, Zhu Y, Fu G. Application of plasma miRNA-145 and miRNA-183 level in diagnosis and prognosis evaluation of acute exacerbation of chronic obstructive pulmonary disease. J Zhengzhou Univ. 2022;57(04):491–495. doi:10.13705/j.issn.1671-6825.2022.01.011
   Google Scholar
• Geng L, Yu X, Ma Y, et al. The levels of miR-155 and miR-483-5p in the serum of patients are potential diagnostic markers for early COPD. Int J Clin Exp Med. 2020;13(4):2347–2354.
   Web of Science ®Google Scholar
• Jiang G. Correlation of serum miRNA-21 and miRNA-126 with lung function and severity of disease in patients with COPD. J Logist Univ PAP. 2022;57(04):491–495. doi:10.13705/j.issn.1671-6825.2022.01.011
   Google Scholar
• Li R, Han B, Yang W, et al. Correlation and clinical significance of miR-128-3p and TLR4 expression in peripheral blood mononuclear cells of patients with AECOPD. J Clin Emerg. 2022;23(09):664–669. doi:10.13201/j.issn.1009-5918.2022.09.011
   Google Scholar
• Li H, Zhao Y, Chen Q, et al. Expression of LncRNA MIR155HG and miR-128-5p in patients with chronic obstructive pulmonary disease. Anhui Med Pharm J. 2023;27(06):1199–1203+1282.
   Google Scholar
• Shen Y, Wang L, Wu Y, et al. A novel diagnostic signature based on three circulating exosomal mircoRNAs for chronic obstructive pulmonary disease. Exp Ther Med. 2021;22(1):717. doi:10.3892/etm.2021.10149
   PubMed Web of Science ®Google Scholar
• Shi XF, He X, Sun ZR, et al. Different expression of circulating microRNA profile and plasma SP-D in Tibetan COPD patients. Sci Rep. 2022;12(1):3388. doi:10.1038/s41598-022-05592-2
   PubMed Web of Science ®Google Scholar
• Soeda S, Ohyashiki JH, Ohtsuki K, et al. Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease. Int J Mol Med. 2013;31(3):533–539. doi:10.3892/ijmm.2013.1251
   PubMed Web of Science ®Google Scholar
• Wang F, Yang B, Qiao J, et al. Serum exosomal microRNA-1258 may as a novel biomarker for the diagnosis of acute exacerbations of chronic obstructive pulmonary disease. Sci Rep. 2023;13(1):18332. doi:10.1038/s41598-023-45592-4
   PubMed Web of Science ®Google Scholar
• Wei X, Lu M, Gao J, et al. LncRNA MEG3 and miR-15a-5p expression and their clinical significance in chronic obstructive pulmonary disease. J Clin Pulmonol. 2022;27(04):505–511.
   Google Scholar
• Zeng Z, Xing C, Zheng H, et al. Expression and clinical significance of plasma miR-145 and miR-183 in patients with acute exacerbation of chronic obstructive pulmonary disease. Chin J Crit Care. 2020;40(01):44–48.
   Google Scholar
• Zhao J, Liu C, Gao L. Expression and significance of microRNA-25 in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease. J Clin Intem Med. 2019;36(06):386–389.
   Google Scholar
• Zhou X, Gao X, Ye X. Expression and clinical significance of miR-125b and miR-146a in serum of patients with AECOPD. J Clin Res. 2021;38(1):61–63.
   Google Scholar
• Li C, Zhang J, Dai L, et al. Study on the expression spectrum of miRNAs in peripheral blood from patients and the value of miR-548h-5p in the diagnosis of chronic obstructive pulmonary disease. Nanosci Nanotechnol Lett. 2020;12(11):1323–1328. doi:10.1166/nnl.2020.3246
   Google Scholar
• Mohamed E, García Martínez DJ, Hosseini MS, et al. Identification of biomarkers for the early detection of non-small cell lung cancer: a systematic review and meta-analysis. Carcinogenesis. 2023;45(1–2):1–22.
   Web of Science ®Google Scholar
• Soccio P, Moriondo G, Lacedonia D, et al. MiRNA and exosomal miRNA as new biomarkers useful to phenotyping severe asthma. Biomolecules. 2023;13(10):1542. doi:10.3390/biom13101542
   PubMed Web of Science ®Google Scholar
• Li X, Xu Y, Liao P. Diagnostic performance of microRNA-29a in active pulmonary tuberculosis: a systematic review and meta-analysis. Clinics. 2023;78:100290. doi:10.1016/j.clinsp.2023.100290
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Ahrari S, Salimian J, et al. p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics. Cell Commun Signal. 2023;21(1):314. doi:10.1186/s12964-023-01337-4
   PubMed Web of Science ®Google Scholar
• Kim HT, Panza P, Kikhi K, et al. WNT/RYK signaling functions as an antiinflammatory modulator in the lung mesenchyme. Proc Natl Acad Sci U S A. 2022;119(24):e2201707119. doi:10.1073/pnas.2201707119
   PubMed Web of Science ®Google Scholar
• Purohit M, Gupta G, Afzal O, et al. Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease. Chem Biol Interact. 2023;371:110334. doi:10.1016/j.cbi.2023.110334
   PubMed Web of Science ®Google Scholar
• Dang X, Qu X, Wang W, et al. Bioinformatic analysis of microRNA and mRNA Regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease. Respir Res. 2017;18(1):4. doi:10.1186/s12931-016-0486-5
   PubMed Web of Science ®Google Scholar
• Leuenberger C, Schuoler C, Bye H, et al. MicroRNA-223 controls the expression of histone deacetylase 2: a novel axis in COPD. J Mol Med. 2016;94(6):725–734. doi:10.1007/s00109-016-1388-1
   PubMed Web of Science ®Google Scholar
• Izzotti A, Calin GA, Arrigo P, et al. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 2009;23(3):806–812. doi:10.1096/fj.08-121384
   PubMed Web of Science ®Google Scholar
• Shi L, Xin Q, Chai R, et al. Ectopic expressed miR-203 contributes to chronic obstructive pulmonary disease via targeting TAK1 and PIK3CA. Int J Clin Exp Pathol. 2015;8(9):10662–10670.
   PubMed Web of Science ®Google Scholar
• Chatila WM, Criner GJ, Hancock WW, et al. Blunted expression of miR-199a-5p in regulatory T cells of patients with chronic obstructive pulmonary disease compared to unaffected smokers. Clin Exp Immunol. 2014;177(1):341–352. doi:10.1111/cei.12325
   PubMed Web of Science ®Google Scholar
• Zeng Z, He S, Lu J, et al. MicroRNA-21 aggravates chronic obstructive pulmonary disease by promoting autophagy. Exp Lung Res. 2018;44(2):89–97. doi:10.1080/01902148.2018.1439548
   PubMed Web of Science ®Google Scholar
• Song Q, Chen P, Liu XM. The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD. Respir Res. 2021;22(1):39. doi:10.1186/s12931-021-01630-1
   PubMed Web of Science ®Google Scholar
• Foye C, Yan IK, David W, et al. Comparison of miRNA quantitation by Nanostring in serum and plasma samples. PLoS One. 2017;12(12):e0189165. doi:10.1371/journal.pone.0189165
   PubMed Web of Science ®Google Scholar
• Ban E, Song EJ. Considerations and suggestions for the reliable analysis of miRNA in plasma using qRT-PCR. Genes. 2022;13(2):328. doi:10.3390/genes13020328
   PubMed Web of Science ®Google Scholar
• Torul H, Yarali E, Eksin E, et al. Paper-based electrochemical biosensors for voltammetric detection of miRNA biomarkers using reduced graphene oxide or MoS(2) nanosheets decorated with gold nanoparticle electrodes. Biosensors. 2021;11(7):236. doi:10.3390/bios11070236
   PubMedGoogle Scholar
• Eksin E, Torul H, Yarali E, Tamer U, Papakonstantinou P, Erdem A. Paper-based electrode assemble for impedimetric detection of miRNA. Talanta. 2021;225:122043. doi:10.1016/j.talanta.2020.122043
   PubMed Web of Science ®Google Scholar